Effect of the Subconscious on Mohs Micrographic Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-12-31

Study Completion Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to determine if relaxation therapy improves patient satisfaction with Mohs micrographic surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Massage Therapy Within a Brain Tumor Setting

NCT00873184

Brain Tumors

COMPLETED NA

Effects of Music Intervention Combined With Progressive Muscle Relaxation in Cancer Patients

NCT05262621

Cancer

COMPLETED NA

Impact of Videos on Patient Anxiety and Satisfaction

NCT03485937

Mohs Surgery

WITHDRAWN NA

Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery

NCT04612491

Anxiety Surgery

TERMINATED

Healing Touch and Relaxation Therapies in Cervical Cancer Patients

NCT00084123

Cervix Neoplasms

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are instructed in relaxation techniques. The goal of this study is to determine how relaxation techniques affect the patient's Mohs micrographic surgery experience.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Basal Cell Carcinoma Squamous Cell Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

I

relaxation tape 1

Group Type EXPERIMENTAL

relaxation therapy 1

Intervention Type BEHAVIORAL

relaxation therapy 1

II

relaxation tape 2

Group Type EXPERIMENTAL

relaxation therapy 2

Intervention Type BEHAVIORAL

relaxation therapy 2

III

relaxation tape 3

Group Type PLACEBO_COMPARATOR

relaxation therapy 3

Intervention Type BEHAVIORAL

relaxation therapy 3

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

relaxation therapy 1

Intervention Type BEHAVIORAL

relaxation therapy 2

Intervention Type BEHAVIORAL

relaxation therapy 3

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 25 and older
* Subjects are undergoing micrographic Mohs surgery for facial basal and squamous cell carcinoma.
* The subjects are in good health.
* The subjects have willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

Exclusion Criteria

* Subjects who have wound healing problems.
* Subjects who have had prior Mohs surgery.
* Subjects who are smokers.
* Subjects who are currently using anticoagulation therapy
* Subjects who have a history of bleeding disorders.
* Subjects who are unable to understand the protocol or to give informed consent
* Subjects with known mental illness or other psychological conditions, such as psychotic disorders, mood disorders, anxiety disorders, cognitive disorders, depression with psychotic features, dissociative disorders.
* Subjects who are taking medications that may affect healing such as prednisone, or any immunosuppressants.
* Subjects who are immunocompromised.
* Subjects who have Diabetes Mellitus or any other condition determined by the PI to affect healing.

Minimum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes